# RNN 2nd Gen Model Thermo Fisher Scientific Inc Measuring & controlling devices, not elsewhere classified

Stock predictor AI models:
Subscribe >> Deal exit on
May 29, 2020
Deal entry on
May 29, 2020
6.19%Expected margin
73.68% successful of 19 deals
$ 349.19 Last close price
at 29-may-2020

TMO

Model's trade recommendations No return for period yet

-4.30% Annual return

$83.91B Market Cap

β 1.14  

TMO

Model (following trade recommendations)

TMO

Underlying stock

S&P 500

Index
Return for period
5.88%
1.78%
52wk return 18.31%
30.79%
16.82%
52wk Range
255.30—349.19
2000.54—2399.63
Sortino ratio -0.17
Sharpe ratio -0.15
Norm. RMSE 6.38%
Downside risk 16.21%
Volatility 0.00%
  • 0.68 (0.33%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.

Industry sector: Medical

Sector classification: Measuring & controlling devices, not elsewhere classified

Deep Learning based analysis and prediction model for Thermo Fisher Scientific Inc (TMO) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for TMO model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for TMO.

Model is being retrained on a regular basis.

Float 400M
P/E 21.09
Shares Outstanding 402M
% Held by Insiders 0.49%
% Held by Institutions 87.20%
EPS (last reported FY) $9.49
EPS (last reported Q) $2.50
EPS, estimated (last reported Q) $2.42
Total revenues $21 B
Net income $2 B